Anzeige
Mehr »
Freitag, 10.07.2026 - Börsentäglich über 12.000 News
Paukenschlag! Diese Gratis-Aktien könnten jetzt Gold wert sein
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
79 Leser
Artikel bewerten:
(0)

B-Temia Inc.: B-Temia and Wistron Join Forces to Launch Keeogo in Asia

B-Temia and Wistron form B-Temia Asia to bring Keeogo to the Asian Market

QUEBEC CITY, June 07, 2018 (GLOBE NEWSWIRE) -- B-Temia Inc., a Canadian biorobotics technology company and market leader in human mobility, entered into a joint venture agreement with Wistron Corporation to launch its Keeogo Dermoskeleton technology in Asia. Wistron is one of the world's largest Original Design Manufacturer (ODM), with more than $34 billion CAD sales, and now a major shareholder of B-Temia since June 2017. Wistron and B-Temia form B-Temia Asia for the marketing of Keeogo in several Asian countries such as China, Japan and Hong Kong. Headquartered in Singapore, B-Temia Asia will benefit from a significant investment from Wistron in exchange for marketing rights for Keeogo products in Asia.

"B-Temia Asia represents the realization of our business plan and our mission to help people regain their independence through mobility. B-Temia is now expanding around the world, which is another demonstration of the real value of our technology and the need to bring modern and revolutionary solutions to the many people living with mobility limitations. In addition, we are excited to expand and strengthen our partnership with Wistron. Over the last year, both organizations have effectively proven their ability to work together for manufacturing transfer to Asia. This joint venture is the next logical step for Wistron, which became a major shareholder of our company in 2017", said Stéphane Bédard, CEO of B-Temia. "This international expansion is a very exciting time for our shareholders said Mr. Bédard.

"Wistron is advancing the development and application of medical technologies to help people with mobility challenges and we are very excited to increase our partnership with B-Temia and to work closely together to develop the human mobility market in Asia. This partnership directly supports our goal of improving people's lives through technology", said Donald Hwang, Chief Technology Officer (CTO) of Wistron Corporation.

About Keeogo Dermoskeleton

Keeogo is a motorized walking assistive device developed by B-Temia. Keeogo, short for "Keep on Going", has been used by people suffering from degenerative diseases such as osteoarthritis of the knee or hip, multiple sclerosis, Parkinson's disease, stroke, incomplete spinal cord injury and other mobility-limiting diseases. Used as a rehabilitation equipment or as a home assistive device to help with daily activities, Keeogo is approved by Health Canada and is commercially available in Canada for purchase or rental. For more information, please visit: www.keeogo.com (http://www.keeogo.com/).

About B-Temia

Founded in 2010, B-Temia Inc. is an innovative Canadian medical device manufacturer that develops and markets leading edge products for the growing market of human augmentation systems. B-Temia operates through two wholly owned subsidiaries, B-Temia Inc. and B-Temia USA Inc., in the medical, industrial and military fields. B-Temia has a patented technology called Dermoskeleton that restores, maintains or enhances user mobility. For more information, please visit: www.b-temia.com (http://www.b-temia.com/).

About Wistron

Wistron Corporation is one of the world's largest companies to produce servers and storage devices for cloud computing and data centers, desktop and laptop computers, smart phones, industrial devices and control units, medical devices, Artificial Intelligence and Big Data Analysis. Wistron's full line of engineering teams enables Wistron's customers to outsource all or part of their product development and manufacturing tasks to focus on their core competencies and further develop their intellectual properties. Wistron manufactures medical products for customers in the medical industry at two ISO 13485-certified factories in Taiwan's Hsinchu Science Park and in Chongqing, China. For more information, please visit: www.wistron.com (http://www.wistron.com/).

Information

Source:
B-Temia Inc.
4780, St-Félix Street, Suite 105
St-Augustin (Québec) G3A 2J9
www.b-temia.com (http://www.b-temia.com/) | www.keeogo.com (http://www.keeogo.com/)
Phone: (418) 653-1010
E-mail: info@b-temia.com (mailto:info@b-temia.com)

Media:
Pamela Borges
VP Market Access & External Affairs
Phone: (418) 653-1010, ext. 223
E-mail: pamela.borges@b-temia.com (mailto:pamela.borges@b-temia.com)





This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: B-Temia Inc. via Globenewswire

© 2018 GlobeNewswire (Europe)
SpaceX-Hype zu teuer – Diese 5 Aktien bieten bessere Chancen
Raumfahrt-Aktien gehören aktuell zu den heißesten Wetten an den Börsen. Spätestens mit dem spektakulären Börsengang von SpaceX ist der Sektor endgültig im Fokus der Anleger angekommen. Fantasien rund um Satellitenkommunikation, Rechenzentren im All und neue Geschäftsmodelle treiben die Kurse immer weiter nach oben.

Doch während die Begeisterung steigt, werden auch die Risiken größer. Viele Space-Start-ups sind inzwischen extrem hoch bewertet, arbeiten noch nicht profitabel und hängen stark von stetigem Kapitalzufluss ab. Schon kleine Rückschläge könnten die ambitionierten Wachstumspläne ins Wanken bringen.

Für Anleger, die vom Boom der Raumfahrt profitieren wollen, lohnt sich daher ein Perspektivwechsel. Statt auf überhitzte Pure Plays zu setzen, rücken etablierte Konzerne in den Fokus – Unternehmen mit jahrzehntelanger Erfahrung, stabilen Cashflows und engen Verbindungen zu Raumfahrtagenturen wie NASA und ESA.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau dieses Profil erfüllen: solide bewertet, operativ stark und bestens positioniert, um langfristig vom Space-Boom zu profitieren.

Jetzt den kostenlosen Report sichern – bevor der Markt die versteckten Gewinner entdeckt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.